DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 2.39% to $9.01 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.40% to 25,520.24 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
The stock's rise snapped a four-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 56.18% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock outperformed some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.18% to $5.44, Fortress Biotech Inc. (FBIO) fell 1.75% to $3.36, and Viking Therapeutics Inc. (VKTX) rose 1.95% to $37.08.
Trading volume (214,743) remained 329,911 below its 50-day average volume of 544,654.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 17, 2026 17:20 ET (21:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments